Amarnath Mukherjee

Title: Amarnath Mukherjee: Innovator in Cancer Gene Delivery

Introduction

Amarnath Mukherjee is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of cancer research through his innovative work in gene delivery systems. His research focuses on developing targeted therapies that can improve treatment outcomes for cancer patients.

Latest Patents

Amarnath Mukherjee holds a patent for an "Aqueous formulation for selective targeting and delivering gene to cancer cells." This invention involves a cationic lipid-based aqueous formulation that includes cationic lipid, dexamethasone, and a neutral co-lipid. The formulation is designed to selectively target and deliver genes to glucocorticoid receptor-expressing cancer cells. The role of glucocorticoid receptors in cancer progression is not fully understood, but this formulation aims to enhance gene delivery while utilizing the apoptosis-inducing properties of dexamethasone.

Career Highlights

Amarnath Mukherjee is affiliated with the Council of Scientific and Industrial Research, where he conducts his research. His work has led to advancements in the understanding of gene delivery mechanisms in cancer therapy. He has a patent count of 1 patent, showcasing his innovative contributions to the field.

Collaborations

Amarnath Mukherjee collaborates with Rajkumar Banerjee, working together to advance their research in cancer treatment methodologies.

Conclusion

Amarnath Mukherjee's innovative work in gene delivery systems represents a significant step forward in cancer research. His patented formulation has the potential to improve therapeutic strategies for cancer patients, highlighting the importance of targeted treatments in modern medicine.